Loading...

Parkash Singh Gill, MD

Title(s)Professor of Medicine
Phone+1 323 865 3909
vCardDownload vCard
    Other Positions
    Title(s)Renette and Marshall Ezralow Family Chair in Cancer Therapeutics


    Collapse Overview 
    Collapse Overview
    Dr. Gill's primary research interest is in studying novel targets that are expressed both in tumor blood vessels as well as the tumor cell. He has demonstrated the ability to identify and validate novel targets, develop novel target therapeutics and collaborate with clinical investigators to conduct early stage clinical trials.

    Dr. Gill has a strong history of clinical investigations and drug development. His clinical investigations led to the approval of three cancer drugs by the FDA. He also served on the advisory panel for the FDA advisory committee on biologics. Over the past several years his work has focused on the identification of novel cancer and cancer blood vessel targets, validation of the targets in various model systems including genetic mouse models.

    Collapse Research 
    Collapse Research Activities and Funding
    VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma
    NIH/NCI R01CA079218Jun 1, 1999 - Feb 28, 2011
    Role: Principal Investigator
    ANGIOGENIC FACTORS AND THEIR EXPRESSION/REGULATION IN KS
    NIH/NHLBI R01HL048499May 1, 1992 - Jan 31, 1996
    Role: Principal Investigator
    PATHOGENISIS OF KAPOSI'S SARCOMA
    NIH/NCI R01CA051621Sep 30, 1989 - Jul 31, 1995
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse In The News
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Sagar V, Vatapalli R, Lysy B, Pamarthy S, Anker JF, Rodriguez Y, Han H, Unno K, Stadler WM, Catalona WJ, Hussain M, Gill PS, Abdulkadir SA. EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells. Cell Death Dis. 2019 Oct 22; 10(11):801. PMID: 31641103.
      View in: PubMed
    2. Tseng CC, Stanciauskas R, Zhang P, Woo D, Wu K, Kelly K, Gill PS, Yu M, Pinaud F, Lee AS. GRP78 regulates CD44v membrane homeostasis and cell spreading in tamoxifen-resistant breast cancer. Life Sci Alliance. 2019 08; 2(4). PMID: 31416894.
      View in: PubMed
    3. Rajarubendra N, Almeida F, Manojlovic Z, Ohe C, Ahmadi N, Cacciamani G, Qiu M, Abreu A, Cai J, Miranda G, Stern MC, Carpten J, Kuhn P, Amin MB, Gill PS, Aron M, Gill IS. Histological Validation of 11Carbon-Acetate Positron Emission Tomography/Computerized Tomography in Detecting Lymph Node Metastases in Prostate Cancer. J Urol. 2019 02; 201(2):332-341. PMID: 30218760.
      View in: PubMed
    4. Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Coan JP, Pearson HE, Bahrar H, Fowler TL, Bednarz BP, Saha S, Yang D, Gill PS, Lingen MW, Saloura V, Villaflor VM, Salgia R, Kimple RJ, Wheeler DL. Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2018 Dec 01; 24(23):6099. PMID: 30510088.
      View in: PubMed
    5. Merchant AA, Jorapur A, McManus A, Liu R, Krasnoperov V, Chaudhry P, Singh M, Harton L, Agajanian M, Kim M, Triche TJ, Druker BJ, Tyner JW, Gill PS. EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT. Blood Adv. 2017 Sep 12; 1(20):1635-1644. PMID: 29296810.
      View in: PubMed
    6. Randolph ME, Cleary MM, Bajwa Z, Svalina MN, Young MC, Mansoor A, Kaur P, Bult CJ, Goros MW, Michalek JE, Xiang S, Keck J, Krasnoperov V, Gill P, Keller C. EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma. PLoS One. 2017; 12(8):e0183161. PMID: 28817624.
      View in: PubMed
    7. Shen J, Ha DP, Zhu G, Rangel DF, Kobielak A, Gill PS, Groshen S, Dubeau L, Lee AS. GRP78 haploinsufficiency suppresses acinar-to-ductal metaplasia, signaling, and mutant Kras-driven pancreatic tumorigenesis in mice. Proc Natl Acad Sci U S A. 2017 05 16; 114(20):E4020-E4029. PMID: 28461470.
      View in: PubMed
    8. Abreu A, Fay C, Park D, Quinn D, Dorff T, Carpten J, Kuhn P, Gill P, Almeida F, Gill I. Robotic salvage retroperitoneal and pelvic lymph node dissection for 'node-only' recurrent prostate cancer: technique and initial series. BJU Int. 2017 09; 120(3):401-408. PMID: 27981731.
      View in: PubMed
    9. Mundbjerg K, Chopra S, Alemozaffar M, Duymich C, Lakshminarasimhan R, Nichols PW, Aron M, Siegmund KD, Ukimura O, Aron M, Stern M, Gill P, Carpten JD, Ørntoft TF, Sørensen KD, Weisenberger DJ, Jones PA, Duddalwar V, Gill I, Liang G. Identifying aggressive prostate cancer foci using a DNA methylation classifier. Genome Biol. 2017 01 12; 18(1):3. PMID: 28081708.
      View in: PubMed
    10. Bhatia S, Hirsch K, Sharma J, Oweida A, Griego A, Keysar S, Jimeno A, Raben D, Krasnoperov V, Gill PS, Pasquale EB, Wang XJ, Karam SD. Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas. Sci Rep. 2016 12 12; 6:38792. PMID: 27941840.
      View in: PubMed
    11. Liang M, Adisetiyo H, Li X, Liu R, Gill P, Roy-Burman P, Jones JO, Mulholland DJ. Correction: Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model. PLoS One. 2016; 11(3):e0152243. PMID: 26998759.
      View in: PubMed
    12. Wu X, Zahari MS, Ma B, Liu R, Renuse S, Sahasrabuddhe NA, Chen L, Chaerkady R, Kim MS, Zhong J, Jelinek C, Barbhuiya MA, Leal-Rojas P, Yang Y, Kashyap MK, Marimuthu A, Ling M, Fackler MJ, Merino V, Zhang Z, Zahnow CA, Gabrielson E, Stearns V, Roa JC, Sukumar S, Gill PS, Pandey A. Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways. Oncotarget. 2015 Oct 06; 6(30):29143-60. PMID: 26356563.
      View in: PubMed
    13. Zhou B, Wang H, Liu R, Wang M, Deng H, Giglio BC, Gill PS, Shan H, Li Z. PET Imaging of Dll4 Expression in Glioblastoma and Colorectal Cancer Xenografts Using (64)Cu-Labeled Monoclonal Antibody 61B. Mol Pharm. 2015 Oct 05; 12(10):3527-34. PMID: 26288060.
      View in: PubMed
    14. Pan CX, Zhang H, Tepper CG, Lin TY, Davis RR, Keck J, Ghosh PM, Gill P, Airhart S, Bult C, Gandara DR, Liu E, de Vere White RW. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy. PLoS One. 2015; 10(8):e0134346. PMID: 26270481.
      View in: PubMed
    15. Liang M, Adisetiyo H, Li X, Liu X, Liu R, Gill P, Roy-Burman P, Jones JO, Mulholland DJ. Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model. PLoS One. 2015; 10(7):e0131232. PMID: 26196517.
      View in: PubMed
    16. Yu H, Liu R, Ma B, Li X, Yen HY, Zhou Y, Krasnoperov V, Xia Z, Zhang X, Bove AM, Buscarini M, Parekh D, Gill IS, Liao Q, Tretiakova M, Quinn D, Zhao J, Gill PS. Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma. Br J Cancer. 2015 Aug 11; 113(4):616-25. PMID: 26180925.
      View in: PubMed
    17. Ferguson BD, Tan YH, Kanteti RS, Liu R, Gayed MJ, Vokes EE, Ferguson MK, Iafrate AJ, Gill PS, Salgia R. Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer. Sci Rep. 2015 Jun 15; 5:10641. PMID: 26073592.
      View in: PubMed
    18. Wang H, Li D, Liu S, Liu R, Yuan H, Krasnoperov V, Shan H, Conti PS, Gill PS, Li Z. Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159. J Nucl Med. 2015 Jun; 56(6):908-13. PMID: 25908833.
      View in: PubMed
    19. Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Coan JP, Pearson HE, Bahrar H, Fowler TL, Bednarz BP, Saha S, Yang D, Gill PS, Lingen MW, Saloura V, Villaflor VM, Salgia R, Kimple RJ, Wheeler DL. AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2015 Jun 01; 21(11):2601-12. PMID: 25767293.
      View in: PubMed
    20. Lin YG, Shen J, Yoo E, Liu R, Yen HY, Mehta A, Rajaei A, Yang W, Mhawech-Fauceglia P, DeMayo FJ, Lydon J, Gill P, Lee AS. Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis. Oncogene. 2015 Oct; 34(43):5418-26. PMID: 25684138.
      View in: PubMed
    21. Ferguson BD, Tretiakova MS, Lingen MW, Gill PS, Salgia R. Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition. Growth Factors. 2014 Dec; 32(6):202-6. PMID: 25391996.
      View in: PubMed
    22. Li X, Choi WW, Yan R, Yu H, Krasnoperov V, Kumar SR, Schuckman A, Klumpp DJ, Pan CX, Quinn D, Gill IS, Gill PS, Liu R. The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder. PLoS One. 2014; 9(8):e105326. PMID: 25148033.
      View in: PubMed
    23. Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Luthar N, Toulany M, Gill PS, Salgia R, Kimple RJ, Wheeler DL. AXL mediates resistance to cetuximab therapy. Cancer Res. 2014 Sep 15; 74(18):5152-64. PMID: 25136066.
      View in: PubMed
    24. Li D, Liu S, Liu R, Park R, Yu H, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. Axl-targeted cancer imaging with humanized antibody h173. Mol Imaging Biol. 2014 Aug; 16(4):511-8. PMID: 24424460.
      View in: PubMed
    25. Liu S, Li D, Guo J, Canale N, Li X, Liu R, Krasnoperov V, Gill PS, Conti PS, Shan H, Li Z. Design, synthesis, and validation of Axl-targeted monoclonal antibody probe for microPET imaging in human lung cancer xenograft. Mol Pharm. 2014 Nov 03; 11(11):3974-9. PMID: 24978094.
      View in: PubMed
    26. Li D, Liu S, Liu R, Zhou Y, Park R, Naga K, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. EphB4-targeted imaging with antibody h131, h131-F(ab')2 and h131-Fab. Mol Pharm. 2013 Dec 02; 10(12):4527-33. PMID: 24147882.
      View in: PubMed
    27. Liu R, Li X, Gao W, Zhou Y, Wey S, Mitra SK, Krasnoperov V, Dong D, Liu S, Li D, Zhu G, Louie S, Conti PS, Li Z, Lee AS, Gill PS. Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis. Clin Cancer Res. 2013 Dec 15; 19(24):6802-11. PMID: 24048331.
      View in: PubMed
    28. Ferguson BD, Liu R, Rolle CE, Tan YH, Krasnoperov V, Kanteti R, Tretiakova MS, Cervantes GM, Hasina R, Hseu RD, Iafrate AJ, Karrison T, Ferguson MK, Husain AN, Faoro L, Vokes EE, Gill PS, Salgia R. The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target. PLoS One. 2013; 8(7):e67668. PMID: 23844053.
      View in: PubMed
    29. Liu R, Ferguson BD, Zhou Y, Naga K, Salgia R, Gill PS, Krasnoperov V. EphB4 as a therapeutic target in mesothelioma. BMC Cancer. 2013 May 30; 13:269. PMID: 23721559.
      View in: PubMed
    30. Liu S, Li D, Park R, Liu R, Xia Z, Guo J, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies. J Nucl Med. 2013 Jul; 54(7):1094-100. PMID: 23667241.
      View in: PubMed
    31. Li D, Liu S, Liu R, Park R, Hughes L, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring. Mol Pharm. 2013 Jan 07; 10(1):329-36. PMID: 23211050.
      View in: PubMed
    32. Hasina R, Mollberg N, Kawada I, Mutreja K, Kanade G, Yala S, Surati M, Liu R, Li X, Zhou Y, Ferguson BD, Nallasura V, Cohen KS, Hyjek E, Mueller J, Kanteti R, El Hashani E, Kane D, Shimada Y, Lingen MW, Husain AN, Posner MC, Waxman I, Villaflor VM, Ferguson MK, Varticovski L, Vokes EE, Gill P, Salgia R. Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers. Cancer Res. 2013 Jan 01; 73(1):184-94. PMID: 23100466.
      View in: PubMed
    33. He M, Zhang W, Bakken T, Schutten M, Toth Z, Jung JU, Gill P, Cannon M, Gao SJ. Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2. Cancer Res. 2012 Jul 15; 72(14):3582-92. PMID: 22593192.
      View in: PubMed
    34. Shi S, Liu J, Joshi SB, Krasnoperov V, Gill P, Middaugh CR, Volkin DB. Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4-HSA. J Pharm Sci. 2012 Jun; 101(6):1969-84. PMID: 22411527.
      View in: PubMed
    35. Trindade A, Djokovic D, Gigante J, Badenes M, Pedrosa AR, Fernandes AC, Lopes-da-Costa L, Krasnoperov V, Liu R, Gill PS, Duarte A. Low-dosage inhibition of Dll4 signaling promotes wound healing by inducing functional neo-angiogenesis. PLoS One. 2012; 7(1):e29863. PMID: 22279550.
      View in: PubMed
    36. Liu R, Trindade A, Sun Z, Kumar R, Weaver FA, Krasnoperov V, Naga K, Duarte A, Gill PS. Inhibition of Notch signaling by Dll4-Fc promotes reperfusion of acutely ischemic tissues. Biochem Biophys Res Commun. 2012 Feb 03; 418(1):173-9. PMID: 22252294.
      View in: PubMed
    37. Djokovic D, Trindade A, Gigante J, Badenes M, Silva L, Liu R, Li X, Gong M, Krasnoperov V, Gill PS, Duarte A. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis. BMC Cancer. 2010 Nov 23; 10:641. PMID: 21092311.
      View in: PubMed
    38. Ahmad A, Groshong JS, Matta H, Schamus S, Punj V, Robinson LJ, Gill PS, Chaudhary PM. Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice. Cancer Biol Ther. 2010 Nov 15; 10(10):1033-40. PMID: 20818173.
      View in: PubMed
    39. Bennett PC, Gill PS, Silverman S, Blann AD, Lip GY. Ethnic differences in common carotid intima-media thickness, and the relationship to cardiovascular risk factors and peripheral arterial disease: the Ethnic-Echocardiographic Heart of England Screening Study. QJM. 2011 Mar; 104(3):245-54. PMID: 20956456.
      View in: PubMed
    40. Brar M, Cheng L, Yuson R, Mojana F, Freeman WR, Gill PS. Ocular safety profile and intraocular pharmacokinetics of an antagonist of EphB4/EphrinB2 signalling. Br J Ophthalmol. 2010 Dec; 94(12):1668-73. PMID: 20934994.
      View in: PubMed
    41. Lee HR, Lee S, Chaudhary PM, Gill P, Jung JU. Immune evasion by Kaposi's sarcoma-associated herpesvirus. Future Microbiol. 2010 Sep; 5(9):1349-65. PMID: 20860481.
      View in: PubMed
    42. Spannuth WA, Mangala LS, Stone RL, Carroll AR, Nishimura M, Shahzad MM, Lee SJ, Moreno-Smith M, Nick AM, Liu R, Jennings NB, Lin YG, Merritt WM, Coleman RL, Vivas-Mejia PE, Zhou Y, Krasnoperov V, Lopez-Berestein G, Gill PS, Sood AK. Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma. Mol Cancer Ther. 2010 Aug; 9(8):2377-88. PMID: 20682653.
      View in: PubMed
    43. Liu R, Gong M, Li X, Zhou Y, Gao W, Tulpule A, Chaudhary PM, Jung J, Gill PS. Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma. Blood. 2010 Jul 15; 116(2):297-305. PMID: 20442363.
      View in: PubMed
    44. Zhang Y, Liu R, Ni M, Gill P, Lee AS. Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP. J Biol Chem. 2010 May 14; 285(20):15065-75. PMID: 20208072.
      View in: PubMed
    45. Krasnoperov V, Kumar SR, Ley E, Li X, Scehnet J, Liu R, Zozulya S, Gill PS. Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth. Am J Pathol. 2010 Apr; 176(4):2029-38. PMID: 20133814.
      View in: PubMed
    46. Liu R, Li X, Tulpule A, Zhou Y, Scehnet JS, Zhang S, Lee JS, Chaudhary PM, Jung J, Gill PS. KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood. 2010 Jan 28; 115(4):887-95. PMID: 19965636.
      View in: PubMed
    47. He S, Kumar SR, Zhou P, Krasnoperov V, Ryan SJ, Gill PS, Hinton DR. Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro. Invest Ophthalmol Vis Sci. 2010 Jan; 51(1):543-52. PMID: 19696168.
      View in: PubMed
    48. Kumar SR, Scehnet JS, Ley EJ, Singh J, Krasnoperov V, Liu R, Manchanda PK, Ladner RD, Hawes D, Weaver FA, Beart RW, Singh G, Nguyen C, Kahn M, Gill PS. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res. 2009 May 01; 69(9):3736-45. PMID: 19366806.
      View in: PubMed
    49. Benedito R, Trindade A, Hirashima M, Henrique D, da Costa LL, Rossant J, Gill PS, Duarte A. Loss of Notch signalling induced by Dll4 causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli. BMC Dev Biol. 2008 Dec 16; 8:117. PMID: 19087347.
      View in: PubMed
    50. Scehnet JS, Ley EJ, Krasnoperov V, Liu R, Manchanda PK, Sjoberg E, Kostecke AP, Gupta S, Kumar SR, Gill PS. The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade. Blood. 2009 Jan 01; 113(1):254-63. PMID: 18836096.
      View in: PubMed
    51. Yavrouian EJ, Sinha UK, Rice DH, Salam MT, Gill PS, Masood R. The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2008 Sep; 134(9):985-91. PMID: 18794445.
      View in: PubMed
    52. Trindade A, Kumar SR, Scehnet JS, Lopes-da-Costa L, Becker J, Jiang W, Liu R, Gill PS, Duarte A. Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos. Blood. 2008 Sep 01; 112(5):1720-9. PMID: 18559979.
      View in: PubMed
    53. Cozen W, Gill PS, Salam MT, Nieters A, Masood R, Cockburn MG, Gauderman WJ, Martínez-Maza O, Nathwani BN, Pike MC, Van Den Berg DJ, Hamilton AS, Deapen DM, Mack TM. Interleukin-2, interleukin-12, and interferon-gamma levels and risk of young adult Hodgkin lymphoma. Blood. 2008 Apr 01; 111(7):3377-82. PMID: 18077789.
      View in: PubMed
    54. Gunarathne A, Patel JV, Potluri R, Gill PS, Hughes EA, Lip GY. Secular trends in the cardiovascular risk profile and mortality of stroke admissions in an inner city, multiethnic population in the United Kingdom (1997-2005). J Hum Hypertens. 2008 Jan; 22(1):18-23. PMID: 17673899.
      View in: PubMed
    55. Gill PS. The origin of Kaposi sarcoma. J Natl Cancer Inst. 2007 Jul 18; 99(14):1063. PMID: 17623793.
      View in: PubMed
    56. Ku TK, Nguyen DC, Karaman M, Gill P, Hacia JG, Crowe DL. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Mol Cancer Res. 2007 Apr; 5(4):351-62. PMID: 17426250.
      View in: PubMed
    57. Bishop KA, Stantchev TS, Hickey AC, Khetawat D, Bossart KN, Krasnoperov V, Gill P, Feng YR, Wang L, Eaton BT, Wang LF, Broder CC. Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. J Virol. 2007 Jun; 81(11):5893-901. PMID: 17376907.
      View in: PubMed
    58. Kumar SR, Masood R, Spannuth WA, Singh J, Scehnet J, Kleiber G, Jennings N, Deavers M, Krasnoperov V, Dubeau L, Weaver FA, Sood AK, Gill PS. The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome. Br J Cancer. 2007 Apr 10; 96(7):1083-91. PMID: 17353927.
      View in: PubMed
    59. Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, Djokovic D, Borges C, Ley EJ, Duarte A, Gill PS. Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 2007 Jun 01; 109(11):4753-60. PMID: 17311993.
      View in: PubMed
    60. Damschroder MM, Widjaja L, Gill PS, Krasnoperov V, Jiang W, Dall'Acqua WF, Wu H. Framework shuffling of antibodies to reduce immunogenicity and manipulate functional and biophysical properties. Mol Immunol. 2007 Apr; 44(11):3049-60. PMID: 17241664.
      View in: PubMed
    61. Sinha UK, Mazhar K, Chinn SB, Dhillon VK, Liu L, Masood R, Rice DH, Gill PS. The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006 Oct; 132(10):1053-9. PMID: 17043250.
      View in: PubMed
    62. Masood R, Kumar SR, Sinha UK, Crowe DL, Krasnoperov V, Reddy RK, Zozulya S, Singh J, Xia G, Broek D, Schönthal AH, Gill PS. EphB4 provides survival advantage to squamous cell carcinoma of the head and neck. Int J Cancer. 2006 Sep 15; 119(6):1236-48. PMID: 16615113.
      View in: PubMed
    63. Kumar SR, Singh J, Xia G, Krasnoperov V, Hassanieh L, Ley EJ, Scehnet J, Kumar NG, Hawes D, Press MF, Weaver FA, Gill PS. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol. 2006 Jul; 169(1):279-93. PMID: 16816380.
      View in: PubMed
    64. Xia G, Kumar SR, Hawes D, Cai J, Hassanieh L, Groshen S, Zhu S, Masood R, Quinn DI, Broek D, Stein JP, Gill PS. Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer. J Urol. 2006 Apr; 175(4):1245-52. PMID: 16515971.
      View in: PubMed
    65. Levine AM, Tulpule A, Quinn DI, Gorospe G, Smith DL, Hornor L, Boswell WD, Espina BM, Groshen SG, Masood R, Gill PS. Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy. J Clin Oncol. 2006 Apr 10; 24(11):1712-9. PMID: 16520466.
      View in: PubMed
    66. Xia G, Kumar SR, Stein JP, Singh J, Krasnoperov V, Zhu S, Hassanieh L, Smith DL, Buscarini M, Broek D, Quinn DI, Weaver FA, Gill PS. EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene. 2006 Feb 02; 25(5):769-80. PMID: 16205642.
      View in: PubMed
    67. He S, Ding Y, Zhou J, Krasnoperov V, Zozulya S, Kumar SR, Ryan SJ, Gill PS, Hinton DR. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization. Invest Ophthalmol Vis Sci. 2005 Dec; 46(12):4772-9. PMID: 16303978.
      View in: PubMed
    68. Kertesz N, Krasnoperov V, Reddy R, Leshanski L, Kumar SR, Zozulya S, Gill PS. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth. Blood. 2006 Mar 15; 107(6):2330-8. PMID: 16322467.
      View in: PubMed
    69. Xia G, Kumar SR, Masood R, Koss M, Templeman C, Quinn D, Zhu S, Reddy R, Krasnoperov V, Gill PS. Up-regulation of EphB4 in mesothelioma and its biological significance. Clin Cancer Res. 2005 Jun 15; 11(12):4305-15. PMID: 15958611.
      View in: PubMed
    70. Xia G, Kumar SR, Masood R, Zhu S, Reddy R, Krasnoperov V, Quinn DI, Henshall SM, Sutherland RL, Pinski JK, Daneshmand S, Buscarini M, Stein JP, Zhong C, Broek D, Roy-Burman P, Gill PS. EphB4 expression and biological significance in prostate cancer. Cancer Res. 2005 Jun 01; 65(11):4623-32. PMID: 15930280.
      View in: PubMed
    71. Buscarini M, Quek ML, Gill P, Xia G, Quinn DI, Stein JP. Molecular prognostic factors in bladder cancer. BJU Int. 2005 Apr; 95(6):739-42. PMID: 15794774.
      View in: PubMed
    72. Hotz HG, Hines OJ, Masood R, Hotz B, Foitzik T, Buhr HJ, Gill PS, Reber HA. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer. Surgery. 2005 Feb; 137(2):192-9. PMID: 15674201.
      View in: PubMed
    73. Noy A, Scadden DT, Lee J, Dezube BJ, Aboulafia D, Tulpule A, Walmsley S, Gill P. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team. J Clin Oncol. 2005 Feb 10; 23(5):990-8. PMID: 15598977.
      View in: PubMed
    74. Cozen W, Diaz-Sanchez D, James Gauderman W, Zadnick J, Cockburn MG, Gill PS, Masood R, Hamilton AS, Jyrala M, Mack TM. Th1 and Th2 cytokines and IgE levels in identical twins with varying levels of cigarette consumption. J Clin Immunol. 2004 Nov; 24(6):617-22. PMID: 15622446.
      View in: PubMed
    75. Masood R, Xia G, Smith DL, Scalia P, Still JG, Tulpule A, Gill PS. Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium. Blood. 2005 Feb 01; 105(3):1310-8. PMID: 15471957.
      View in: PubMed
    76. Frankel AE, Gill PS. VEGF and myeloid leukemias. Leuk Res. 2004 Jul; 28(7):675-7. PMID: 15158088.
      View in: PubMed
    77. Wang JF, Liu ZY, Anand AR, Zhang X, Brown LF, Dezube BJ, Gill P, Ganju RK. Alpha-chemokine-mediated signal transduction in human Kaposi's sarcoma spindle cells. Biochim Biophys Acta. 2004 May 03; 1691(2-3):129-39. PMID: 15110993.
      View in: PubMed
    78. Cozen W, Gill PS, Ingles SA, Masood R, Martínez-Maza O, Cockburn MG, Gauderman WJ, Pike MC, Bernstein L, Nathwani BN, Salam MT, Danley KL, Wang W, Gage J, Gundell-Miller S, Mack TM. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood. 2004 Apr 15; 103(8):3216-21. PMID: 15070705.
      View in: PubMed
    79. Sinha UK, Kundra A, Scalia P, Smith DL, Parsa B, Masood R, Gill PS. Expression of EphB4 in head and neck squamous cell carcinoma. Ear Nose Throat J. 2003 Nov; 82(11):866, 869-70, 887. PMID: 14661437.
      View in: PubMed
    80. Smith DL, Cai J, Zhu S, Wei W, Fukumoto J, Sharma S, Masood R, Gill PS. Natural killer cell cytolytic activity is necessary for in vivo antitumor activity of the dipeptide L-glutamyl-L-tryptophan. Int J Cancer. 2003 Sep 10; 106(4):528-33. PMID: 12845648.
      View in: PubMed
    81. Masood R, Kundra A, Zhu S, Xia G, Scalia P, Smith DL, Gill PS. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int J Cancer. 2003 May 01; 104(5):603-10. PMID: 12594815.
      View in: PubMed
    82. Bernstein ZP, Chanan-Khan A, Miller KC, Northfelt DW, Lopez-Berestein G, Gill PS. A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Cancer. 2002 Dec 15; 95(12):2555-61. PMID: 12467070.
      View in: PubMed
    83. Tulpule A, Groopman J, Saville MW, Harrington W, Friedman-Kien A, Espina BM, Garces C, Mantelle L, Mettinger K, Scadden DT, Gill PS. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer. 2002 Jul 01; 95(1):147-54. PMID: 12115328.
      View in: PubMed
    84. Hotz HG, Gill PS, Masood R, Hotz B, Buhr HJ, Foitzik T, Hines OJ, Reber HA. Specific targeting of tumor vasculature by diphtheria toxin-vascular endothelial growth factor fusion protein reduces angiogenesis and growth of pancreatic cancer. J Gastrointest Surg. 2002 Mar-Apr; 6(2):159-66; discussion 166. PMID: 11992800.
      View in: PubMed
    85. Tulpule A, Sherrod A, Dharmapala D, Young LL, Espina BM, Sanchez MN, Gill PS, Levine AM. Multidrug resistance (MDR-1) expression in AIDS-related lymphomas. Leuk Res. 2002 Feb; 26(2):121-7. PMID: 11755462.
      View in: PubMed
    86. Masood R, Cesarman E, Smith DL, Gill PS, Flore O. Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. Am J Pathol. 2002 Jan; 160(1):23-9. PMID: 11786394.
      View in: PubMed
    87. Masood R, Gordon EM, Whitley MD, Wu BW, Cannon P, Evans L, Anderson WF, Gill P, Hall FL. Retroviral vectors bearing IgG-binding motifs for antibody-mediated targeting of vascular endothelial growth factor receptors. Int J Mol Med. 2001 Oct; 8(4):335-43. PMID: 11562769.
      View in: PubMed
    88. Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood. 2001 Sep 15; 98(6):1904-13. PMID: 11535528.
      View in: PubMed
    89. Masood R, Cai J, Tulpule A, Zheng T, Hamilton A, Sharma S, Espina BM, Smith DL, Gill PS. Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma. Clin Cancer Res. 2001 Sep; 7(9):2693-702. PMID: 11555581.
      View in: PubMed
    90. Carracedo A, Beckmann A, Bengs A, Brinkmann B, Caglia A, Capelli C, Gill P, Gusmão L, Hagelberg C, Hohoff C, Hoste B, Kihlgren A, Kloosterman A, Myhre Dupuy B, Morling N, O'Donnell G, Parson W, Phillips C, Pouwels M, Scheithauer R, Schmitter H, Schneider PM, Schumm J, Skitsa I, Stradmann-Bellinghausen B, Stuart M, Syndercombe Court D, Vide C. Results of a collaborative study of the EDNAP group regarding the reproducibility and robustness of the Y-chromosome STRs DYS19, DYS389 I and II, DYS390 and DYS393 in a PCR pentaplex format. Forensic Sci Int. 2001 Jun 01; 119(1):28-41. PMID: 11348791.
      View in: PubMed
    91. Levine AM, Seneviratne L, Espina BM, Wohl AR, Tulpule A, Nathwani BN, Gill PS. Evolving characteristics of AIDS-related lymphoma. Blood. 2000 Dec 15; 96(13):4084-90. PMID: 11110677.
      View in: PubMed
    92. Masood R, Nagpal S, Zheng T, Cai J, Tulpule A, Smith DL, Gill PS. Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist. Blood. 2000 Nov 01; 96(9):3188-94. PMID: 11050002.
      View in: PubMed
    93. Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res. 2000 Aug 01; 60(15):4066-9. PMID: 10945611.
      View in: PubMed
    94. Edelman DC, Ketema F, Saville RD, Herman J, Sill AM, Gill PS, Blattner WA, Constantine NT. Specifics on the refinement and application of two serological assays for the detection of antibodies to HHV-8. J Clin Virol. 2000 May; 16(3):225-37. PMID: 10738141.
      View in: PubMed
    95. Tulpule A, Scadden DT, Espina BM, Cabriales S, Howard W, Shea K, Gill PS. Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma. J Clin Oncol. 2000 Feb; 18(4):716-23. PMID: 10673512.
      View in: PubMed
    96. Munshi N, Groopman JE, Gill PS, Ganju RK. c-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi's sarcoma cells. J Immunol. 2000 Feb 01; 164(3):1169-74. PMID: 10640727.
      View in: PubMed
    97. Cai J, Zheng T, Masood R, Smith DL, Hinton DR, Kim CN, Fang G, Bhalla K, Gill PS. Paclitaxel Induces Apoptosis in AIDS-Related Kaposi's Sarcoma Cells. Sarcoma. 2000; 4(1-2):37-45. PMID: 18521433.
      View in: PubMed
    98. Lee RK, Cai JP, Deyev V, Gill PS, Cabral L, Wood C, Agarwal RP, Xia W, Boise LH, Podack E, Harrington WJ. Azidothymidine and interferon-alpha induce apoptosis in herpesvirus-associated lymphomas. Cancer Res. 1999 Nov 01; 59(21):5514-20. PMID: 10554028.
      View in: PubMed
    99. Kundu RK, Sangiorgi F, Wu LY, Pattengale PK, Hinton DR, Gill PS, Maxson R. Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma. Blood. 1999 Jul 01; 94(1):275-82. PMID: 10381523.
      View in: PubMed
    100. Gill PS, Tulpule A, Espina BM, Cabriales S, Bresnahan J, Ilaw M, Louie S, Gustafson NF, Brown MA, Orcutt C, Winograd B, Scadden DT. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol. 1999 Jun; 17(6):1876-83. PMID: 10561228.
      View in: PubMed
    101. Masood R, McGarvey ME, Zheng T, Cai J, Arora N, Smith DL, Sloane N, Gill PS. Antineoplastic urinary protein inhibits Kaposi's sarcoma and angiogenesis in vitro and in vivo. Blood. 1999 Feb 01; 93(3):1038-44. PMID: 9920854.
      View in: PubMed
    102. Mihalcea AM, Smith DL, Monini P, Sgadari C, Ensoli B, Gill PS. Treatment update for AIDS-related Kaposi's sarcoma. AIDS. 1999; 13 Suppl A:S215-25. PMID: 10885778.
      View in: PubMed
    103. Arora N, Masood R, Zheng T, Cai J, Smith DL, Gill PS. Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells. Cancer Res. 1999 Jan 01; 59(1):183-8. PMID: 9892205.
      View in: PubMed
    104. Tulpule A, Yung RC, Wernz J, Espina BM, Myers A, Scadden DT, Cabriales S, Ilaw M, Boswell W, Gill PS. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma. J Clin Oncol. 1998 Oct; 16(10):3369-74. PMID: 9779714.
      View in: PubMed
    105. Willis MC, Collins BD, Zhang T, Green LS, Sebesta DP, Bell C, Kellogg E, Gill SC, Magallanez A, Knauer S, Bendele RA, Gill PS, Janjic N, Collins B. Liposome-anchored vascular endothelial growth factor aptamers. Bioconjug Chem. 1998 Sep-Oct; 9(5):573-82. PMID: 9736491.
      View in: PubMed
    106. McGarvey ME, Tulpule A, Cai J, Zheng T, Masood R, Espina B, Arora N, Smith DL, Gill PS. Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol. 1998 Sep; 10(5):413-21. PMID: 9800111.
      View in: PubMed
    107. Gill PS, Tsai YC, Rao AP, Spruck CH, Zheng T, Harrington WA, Cheung T, Nathwani B, Jones PA. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci U S A. 1998 Jul 07; 95(14):8257-61. PMID: 9653174.
      View in: PubMed
    108. Chatlynne LG, Lapps W, Handy M, Huang YQ, Masood R, Hamilton AS, Said JW, Koeffler HP, Kaplan MH, Friedman-Kien A, Gill PS, Whitman JE, Ablashi DV. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood. 1998 Jul 01; 92(1):53-8. PMID: 9639499.
      View in: PubMed
    109. Dezube BJ, Von Roenn JH, Holden-Wiltse J, Cheung TW, Remick SC, Cooley TP, Moore J, Sommadossi JP, Shriver SL, Suckow CW, Gill PS. Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team. J Clin Oncol. 1998 Apr; 16(4):1444-9. PMID: 9552050.
      View in: PubMed
    110. Cozen W, Masood R, Mack T, Gill PS, Ablashi DV. Seroprevalence of Kaposi's sarcoma-associated herpes virus antibody in young adult Hodgkin's disease. Blood. 1998 Jan 15; 91(2):724. PMID: 9439351.
      View in: PubMed
    111. Cabriales S, Bresnahan J, Testa D, Espina BM, Scadden DT, Ross M, Gill PS. Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases. Oncol Nurs Forum. 1998 Jan-Feb; 25(1):67-70. PMID: 9460774.
      View in: PubMed
    112. Gill PS, McLaughlin T, Espina BM, Tulpule A, Louie S, Lunardi-Iskandar Y, Gallo RC. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma. J Natl Cancer Inst. 1997 Dec 03; 89(23):1797-802. PMID: 9392621.
      View in: PubMed
    113. Gill PS, Mitsuyasu RT, Montgomery T, Huang J, Cabriales S, Testa M, Espina BM, Levine AM, Miles SA. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma. Cancer J Sci Am. 1997 Sep-Oct; 3(5):278-83. PMID: 9327151.
      View in: PubMed
    114. Bazarbachi A, Soriano V, Pawson R, Vallejo A, Moudgil T, Matutes E, Peries J, Molina A, de The H, Schulz TF, Catovsky D, Gill PS. Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol. 1997 Sep; 98(4):927-33. PMID: 9326191.
      View in: PubMed
    115. Jie C, Tulpule A, Zheng T, Masood R, Espina B, Gill PS. Treatment of epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol. 1997 Sep; 9(5):433-9. PMID: 9327221.
      View in: PubMed
    116. Nagpal S, Cai J, Zheng T, Patel S, Masood R, Lin GY, Friant S, Johnson A, Smith DL, Chandraratna RA, Gill PS. Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma. Mol Cell Biol. 1997 Jul; 17(7):4159-68. PMID: 9199351.
      View in: PubMed
    117. Cai J, Zheng T, Lotz M, Zhang Y, Masood R, Gill P. Glucocorticoids induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor-beta. Blood. 1997 Mar 01; 89(5):1491-500. PMID: 9057628.
      View in: PubMed
    118. Masood R, Cai J, Zheng T, Smith DL, Naidu Y, Gill PS. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci U S A. 1997 Feb 04; 94(3):979-84. PMID: 9023368.
      View in: PubMed
    119. Cai J, Zheng T, Murphy J, Waters CA, Lin GY, Gill PS. IL-4R expression in AIDS-KS cells and response to rhIL-4 and IL-4 toxin (DAB389-IL-4). Invest New Drugs. 1997; 15(4):279-87. PMID: 9547670.
      View in: PubMed
    120. Tulpule A, Joshi B, DeGuzman N, Espina BM, Mocharnuk R, Prakash O, Templeton D, Levine AM, Gill PS. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma. Ann Oncol. 1997 Jan; 8(1):79-83. PMID: 9093711.
      View in: PubMed
    121. Gill PS, Lunardi-Ishkandar Y, Louie S, Tulpule A, Zheng T, Espina BM, Besnier JM, Hermans P, Levine AM, Bryant JL, Gallo RC. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med. 1996 Oct 24; 335(17):1261-9. PMID: 8857005.
      View in: PubMed
    122. Mori N, Gill PS, Mougdil T, Murakami S, Eto S, Prager D. Interleukin-10 gene expression in adult T-cell leukemia. Blood. 1996 Aug 01; 88(3):1035-45. PMID: 8704212.
      View in: PubMed
    123. Levine AM, Tulpule A, Espina B, Boswell W, Buckley J, Rasheed S, Stain S, Parker J, Nathwani B, Gill PS. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time. Cancer. 1996 Aug 01; 78(3):517-26. PMID: 8697399.
      View in: PubMed
    124. Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol. 1996 Aug; 14(8):2353-64. PMID: 8708728.
      View in: PubMed
    125. Madigan MC, Sadun AA, Rao NS, Dugel PU, Tenhula WN, Gill PS. Tumor necrosis factor-alpha (TNF-alpha)-induced optic neuropathy in rabbits. Neurol Res. 1996 Apr; 18(2):176-84. PMID: 9162875.
      View in: PubMed
    126. Formenti SC, Chak L, Gill P, Buess EM, Hill CK. Increased radiosensitivity of normal tissue fibroblasts in patients with acquired immunodeficiency syndrome (AIDS) and with Kaposi's sarcoma. Int J Radiat Biol. 1995 Oct; 68(4):411-2. PMID: 7594966.
      View in: PubMed
    127. Gill PS, Harrington W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, Bernstein-Singer M, Espina BM, Cabral L, Allen S. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med. 1995 Jun 29; 332(26):1744-8. PMID: 7760890.
      View in: PubMed
    128. Louie S, Cai J, Law R, Lin G, Lunardi-Iskandar Y, Jung B, Masood R, Gill P. Effects of interleukin-1 and interleukin-1 receptor antagonist in AIDS-Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15; 8(5):455-60. PMID: 7697441.
      View in: PubMed
    129. Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol. 1995 Apr; 13(4):996-1003. PMID: 7707129.
      View in: PubMed
    130. Guo WX, Gill PS, Antakly T. Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation. Cancer Res. 1995 Feb 15; 55(4):823-9. PMID: 7850796.
      View in: PubMed
    131. Gill PS, Miles SA, Mitsuyasu RT, Montgomery T, McCarthy S, Espina BM, Feldstein M, Levine AM. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma. AIDS. 1994 Dec; 8(12):1695-9. PMID: 7534090.
      View in: PubMed
    132. Tak T, Rashtian M, De Tar M, Chandraratna PA, Gill P. An unusual case of metastatic intracardiac plasmacytoma. Can J Cardiol. 1994 Oct; 10(8):857-60. PMID: 7954022.
      View in: PubMed
    133. Keung YK, Lau S, Gill P. Extramedullary plasmacytoma of the heart presenting as cardiac emergency. Review of literature. Am J Clin Oncol. 1994 Oct; 17(5):427-9. PMID: 8092116.
      View in: PubMed
    134. Masood R, Lunardi-Iskandar Y, Jean LF, Murphy JR, Waters C, Gallo RC, Gill P. Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6. AIDS Res Hum Retroviruses. 1994 Aug; 10(8):969-75. PMID: 7811548.
      View in: PubMed
    135. Masood R, Lunardi-Iskandar Y, Moudgil T, Zhang Y, Law RE, Huang CL, Puri RK, Levine AM, Gill PS. IL-10 inhibits HIV-1 replication and is induced by tat. Biochem Biophys Res Commun. 1994 Jul 15; 202(1):374-83. PMID: 8037735.
      View in: PubMed
    136. Kumar SR, Gill PS, Wagner DG, Dugel PU, Moudgil T, Rao NA. Human T-cell lymphotropic virus type I-associated retinal lymphoma. A clinicopathologic report. Arch Ophthalmol. 1994 Jul; 112(7):954-9. PMID: 8031276.
      View in: PubMed
    137. Cai J, Gill PS, Masood R, Chandrasoma P, Jung B, Law RE, Radka SF. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol. 1994 Jul; 145(1):74-9. PMID: 8030759.
      View in: PubMed
    138. Hamilton AS, Radka SF, Bernstein L, Gill PS, Gonsalves M, Naemura JR, Ross RK. Relationship of serum levels of oncostatin M to AIDS-related and classic Kaposi's sarcoma. J Acquir Immune Defic Syndr. 1994 Apr; 7(4):410-4. PMID: 7907664.
      View in: PubMed
    139. Gill PS, Parkinson D. Solid tumor treatment workshop summary. Leukemia. 1994; 8 Suppl 3:S83-4. PMID: 7808033.
      View in: PubMed
    140. Gill PS, Espina BM, Moudgil T, Kidane S, Esplin JA, Tulpule A, Levine AM. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study. Leukemia. 1994; 8 Suppl 3:S26-32. PMID: 7808021.
      View in: PubMed
    141. Masood R, Husain SR, Rahman A, Gill P. Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin. AIDS Res Hum Retroviruses. 1993 Aug; 9(8):741-6. PMID: 8217343.
      View in: PubMed
    142. Gill PS, Bernstein-Singer M, Espina BM, Rarick M, Magy F, Montgomery T, Berry MS, Levine A. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma. AIDS. 1992 Dec; 6(12):1477-81. PMID: 1283520.
      View in: PubMed
    143. Dugel PU, Gill PS, Frangieh GT, Rao NA. Treatment of ocular adnexal Kaposi's sarcoma in acquired immune deficiency syndrome. Ophthalmology. 1992 Jul; 99(7):1127-32. PMID: 1495793.
      View in: PubMed
    144. Rosenblum L, Darrow W, Witte J, Cohen J, French J, Gill PS, Potterat J, Sikes K, Reich R, Hadler S. Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States. JAMA. 1992 May 13; 267(18):2477-81. PMID: 1573724.
      View in: PubMed
    145. Ireland-Gill A, Espina BM, Akil B, Gill PS. Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma using bleomycin-containing combination chemotherapy regimens. Semin Oncol. 1992 Apr; 19(2 Suppl 5):32-6; discussion 36-7. PMID: 1384142.
      View in: PubMed
    146. Rarick MU, Montgomery T, Groshen S, Sullivan-Halley J, Jamin D, Mazumder A, Gill PS, Loureiro C, Levine AM. Intravenous immunoglobulin in the treatment of human immunodeficiency virus-related thrombocytopenia. Am J Hematol. 1991 Dec; 38(4):261-6. PMID: 1746533.
      View in: PubMed
    147. Gill PS. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. Semin Oncol. 1991 Oct; 18(5 Suppl 7):53-7. PMID: 1719642.
      View in: PubMed
    148. Gill PS. Pathogenesis of HIV-related malignancies. Curr Opin Oncol. 1991 Oct; 3(5):867-71. PMID: 1751580.
      View in: PubMed
    149. Gill PS, Rarick M, McCutchan JA, Slater L, Parker B, Muchmore E, Bernstein-Singer M, Akil B, Espina BM, Krailo M. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am J Med. 1991 Apr; 90(4):427-33. PMID: 1707230.
      View in: PubMed
    150. Zaharia L, Gill PS. Primary cardiac lymphoma. Am J Clin Oncol. 1991 Apr; 14(2):142-5. PMID: 2028920.
      View in: PubMed
    151. Rarick MU, Loureiro C, Groshen S, Sullivan-Halley J, Gill PS, Bernstein-Singer M, Levine AM. Serum erythropoietin titers in patients with human immunodeficiency virus (HIV) infection and anemia. J Acquir Immune Defic Syndr. 1991; 4(6):593-7. PMID: 1673713.
      View in: PubMed
    152. Kumar R, Gill PS, Rattan PJ. Variations in plasma trace-elements concentration during fracture healing in dogs. Indian J Physiol Pharmacol. 1991 Jan; 35(1):58-60. PMID: 1917014.
      View in: PubMed
    153. Gill PS, Naidu YM, Salahuddin SZ. Recent advances in AIDS-related Kaposi's sarcoma. Curr Opin Oncol. 1990 Dec; 2(6):1161-6. PMID: 2099846.
      View in: PubMed
    154. Dugel PU, Gill PS, Frangieh GT, Rao NA. Ocular adnexal Kaposi's sarcoma in acquired immunodeficiency syndrome. Am J Ophthalmol. 1990 Nov 15; 110(5):500-3. PMID: 2240135.
      View in: PubMed
    155. Gill PS, Rarick MU, Bernstein-Singer M, Espina BM, Jones B, Montgomery T, Sharma D, Rasheed S, Levine AM. Interferon-alpha maintenance therapy after cytotoxic chemotherapy for treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Biol Response Mod. 1990 Oct; 9(5):512-6. PMID: 2254762.
      View in: PubMed
    156. Gill P, Rarick M, Bernstein-Singer M, Harb M, Espina BM, Shaw V, Levine A. Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol. 1990 Aug; 13(4):315-9. PMID: 1696066.
      View in: PubMed
    157. Laine L, Amerian J, Rarick M, Harb M, Gill PS. The response of symptomatic gastrointestinal Kaposi's sarcoma to chemotherapy: a prospective evaluation using an endoscopic method of disease quantification. Am J Gastroenterol. 1990 Aug; 85(8):959-61. PMID: 1695812.
      View in: PubMed
    158. Dugel PU, Gill PS, Frangieh GT, Rasheed S, Rao NA. Particles resembling retrovirus and conjunctival Kaposi's sarcoma. Am J Ophthalmol. 1990 Jul 15; 110(1):86-7. PMID: 2368827.
      View in: PubMed
    159. Gill PS, Rarick MU, Espina B, Loureiro C, Bernstein-Singer M, Akil B, Levine AM. Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy. Cancer. 1990 Mar 01; 65(5):1074-8. PMID: 1689209.
      View in: PubMed
    160. Khabbaz RF, Darrow WW, Hartley TM, Witte J, Cohen JB, French J, Gill PS, Potterat J, Sikes RK, Reich R. Seroprevalence and risk factors for HTLV-I/II infection among female prostitutes in the United States. JAMA. 1990 Jan 05; 263(1):60-4. PMID: 2293689.
      View in: PubMed
    161. Rarick MU, Gill PS, Montgomery T, Bernstein-Singer M, Jones B, Levine AM. Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine. Ann Oncol. 1990; 1(2):147-9. PMID: 1706615.
      View in: PubMed
    162. Shibata D, Brynes RK, Rabinowitz A, Hanson CA, Slovak ML, Spira TJ, Gill P. Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1). Ann Intern Med. 1989 Dec 01; 111(11):871-5. PMID: 2573306.
      View in: PubMed
    163. Gill PS, Brynes R. Recent advances in AIDS-related Kaposi's sarcoma. Curr Opin Oncol. 1989 Oct; 1(1):57-61. PMID: 2489949.
      View in: PubMed
    164. Gill PS, Akil B, Colletti P, Rarick M, Loureiro C, Bernstein-Singer M, Krailo M, Levine AM. Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. Am J Med. 1989 Jul; 87(1):57-61. PMID: 2472743.
      View in: PubMed
    165. Gill PS, Loureiro C, Bernstein-Singer M, Rarick MU, Sattler F, Levine AM. Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989 Jun 01; 110(11):937-40. PMID: 2719427.
      View in: PubMed
    166. Formenti SC, Gill PS, Lean E, Rarick M, Meyer PR, Boswell W, Petrovich Z, Chak L, Levine AM. Primary central nervous system lymphoma in AIDS. Results of radiation therapy. Cancer. 1989 Mar 15; 63(6):1101-7. PMID: 2917314.
      View in: PubMed
    167. Adams JS, Fernandez M, Gacad MA, Gill PS, Endres DB, Rasheed S, Singer FR. Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. Blood. 1989 Jan; 73(1):235-9. PMID: 2910361.
      View in: PubMed
    168. Bertram JH, Snyder HW, Gill PS, Shulman I, Henry DH, Jenkins D, Kiprov DD. Protein A immunoadsorption therapy in HIV-related immune thrombocytopenia: a preliminary report. Artif Organs. 1988 Dec; 12(6):484-90. PMID: 3063241.
      View in: PubMed
    169. Jamin D, Shulman I, Lam HT, Aguilar S, Shields M, Cohen J, Gill P, Levine A. Production of a positive direct antiglobulin test due to suramin. Arch Pathol Lab Med. 1988 Sep; 112(9):898-900. PMID: 3415441.
      View in: PubMed
    170. Loureiro C, Gill PS, Meyer PR, Rhodes R, Rarick MU, Levine AM. Autopsy findings in AIDS-related lymphoma. Cancer. 1988 Aug 15; 62(4):735-9. PMID: 3395957.
      View in: PubMed
    171. Hu E, Hufford S, Lukes R, Bernstein-Singer M, Sobel G, Gill P, Pinter-Brown L, Rarick M, Rosen P, Brynes R. Third-World Hodgkin's disease at Los Angeles County-University of Southern California Medical Center. J Clin Oncol. 1988 Aug; 6(8):1285-92. PMID: 3411341.
      View in: PubMed
    172. Chak LY, Gill PS, Levine AM, Meyer PR, Anselmo JA, Petrovich Z. Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Clin Oncol. 1988 May; 6(5):863-7. PMID: 3367189.
      View in: PubMed
    173. Gill PS, Levine AM. HIV-related malignant lymphoma: clinical aspects, treatment, and pathogenesis. Cancer Invest. 1988; 6(4):413-6. PMID: 3179773.
      View in: PubMed
    174. Gill PS, Rarick M, Brynes RK, Causey D, Loureiro C, Levine AM. Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1987 Oct; 107(4):502-5. PMID: 3477107.
      View in: PubMed
    175. Loureiro C, Gill PS, Rarick M, Levine AM. Red hair and hyperpigmentation in a black man after chemotherapy. J Clin Oncol. 1987 Oct; 5(10):1705-6. PMID: 3655865.
      View in: PubMed
    176. Gill PS, Levine AM, Krailo M, Rarick MU, Loureiro C, Deyton L, Meyer P, Rasheed S. AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol. 1987 Sep; 5(9):1322-8. PMID: 2442321.
      View in: PubMed
    177. Turner RR, Levine AM, Gill PS, Parker JW, Meyer PR. Progressive histopathologic abnormalities in the persistent generalized lymphadenopathy syndrome. Am J Surg Pathol. 1987 Aug; 11(8):625-32. PMID: 3618883.
      View in: PubMed
    178. Turner RR, Meyer PR, Taylor CR, Gill PS, Hofman FM, Nichols P, Rasheed S, Levine AM. Immunohistology of persistent generalized lymphadenopathy. Evidence for progressive lymph node abnormalities in some patients. Am J Clin Pathol. 1987 Jul; 88(1):10-9. PMID: 3300263.
      View in: PubMed
    179. Levine AM, Gill PS, Muggia F. Malignancies in the acquired immunodeficiency syndrome. Curr Probl Cancer. 1987 Jul-Aug; 11(4):209-55. PMID: 3608570.
      View in: PubMed
    180. Levine AM, Gill PS. AIDS-related malignant lymphoma: clinical presentation and treatment approaches. Oncology (Williston Park). 1987 Jun; 1(4):41-6. PMID: 3079481.
      View in: PubMed
    181. Burkes RL, Abo W, Levine AM, Linker-Israeli M, Parker JW, Gill PS, Krailo M, Horwitz DA. Characterization of immunologic function in homosexual men with persistent, generalized lymphadenopathy and acquired immune deficiency syndrome. Cancer. 1987 Feb 15; 59(4):731-8. PMID: 3492262.
      View in: PubMed
    182. Gill PS, Chandraratna PA, Meyer PR, Levine AM. Malignant lymphoma: cardiac involvement at initial presentation. J Clin Oncol. 1987 Feb; 5(2):216-24. PMID: 3543244.
      View in: PubMed
    183. Bertram JH, Gill PS, Levine AM, Boquiren D, Hoffman FM, Meyer P, Mitchell MS. Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlation. Blood. 1986 Sep; 68(3):752-61. PMID: 3488778.
      View in: PubMed
    184. Gill PS, Levine AM, Meyer PR, Aguilar SL, Rarick M, Parker JW, Rasheed S. Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population. Arch Intern Med. 1986 Aug; 146(8):1501-4. PMID: 3015064.
      View in: PubMed
    185. Levine AM, Gill PS, Cohen J, Hawkins JG, Formenti SC, Aguilar S, Meyer PR, Krailo M, Parker J, Rasheed S. Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results. Ann Intern Med. 1986 Jul; 105(1):32-7. PMID: 2424353.
      View in: PubMed
    186. Burkes RL, Sherrod AE, Stewart ML, Gill PS, Aguilar S, Taylor CR, Krailo MD, Levine AM. Serum beta-2 microglobulin levels in homosexual men with AIDS and with persistent, generalized lymphadenopathy. Cancer. 1986 Jun 01; 57(11):2190-2. PMID: 3008977.
      View in: PubMed
    187. Burkes RL, Meyer PR, Gill PS, Parker JW, Rasheed S, Levine AM. Rectal lymphoma in homosexual men. Arch Intern Med. 1986 May; 146(5):913-5. PMID: 3457557.
      View in: PubMed
    188. Gill PS, Meyer PR, Pavlova Z, Levine AM. B cell acute lymphocytic leukemia in adults. Clinical, morphologic, and immunologic findings. J Clin Oncol. 1986 May; 4(5):737-43. PMID: 3486255.
      View in: PubMed
    189. Rasheed S, Norman GL, Gill PS, Meyer PR, Cheng L, Levine AM. Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area. Virology. 1986 Apr 15; 150(1):1-9. PMID: 3006329.
      View in: PubMed
    190. Levine AM, Meyer PR, Gill PS, Burkes RL, Krailo M, Aguilar S, Parker JW. Results of initial lymph node biopsy in homosexual men with generalized lymphadenopathy. J Clin Oncol. 1986 Feb; 4(2):165-9. PMID: 3944603.
      View in: PubMed
    191. Levine AM, Gill PS, Rasheed S. Human retrovirus-associated lymphoproliferative disorders in homosexual men. Prog Allergy. 1986; 37:244-58. PMID: 3008165.
      View in: PubMed
    192. Gill PS, Graham RA, Boswell W, Meyer P, Krailo M, Levine AM. A comparison of imaging, clinical, and pathologic aspects of space-occupying lesions within the brain in patients with acquired immune deficiency syndrome. Am J Physiol Imaging. 1986; 1(3):134-41. PMID: 3451758.
      View in: PubMed
    193. Levine AM, Gill PS, Meyer PR, Burkes RL, Ross R, Dworsky RD, Krailo M, Parker JW, Lukes RJ, Rasheed S. Retrovirus and malignant lymphoma in homosexual men. JAMA. 1985 Oct 11; 254(14):1921-5. PMID: 2995692.
      View in: PubMed
    194. Burkes RL, Gal AA, Stewart ML, Gill PS, Abo W, Levine AM. Simultaneous occurrence of Pneumocystis carinii pneumonia, cytomegalovirus infection, Kaposi's sarcoma, and B-immunoblastic sarcoma in a homosexual man. JAMA. 1985 Jun 21; 253(23):3425-8. PMID: 2987560.
      View in: PubMed
    195. Gill PS, Levine AM, Meyer PR, Boswell WD, Burkes RL, Parker JW, Hofman FM, Dworsky RL, Lukes RJ. Primary central nervous system lymphoma in homosexual men. Clinical, immunologic, and pathologic features. Am J Med. 1985 May; 78(5):742-8. PMID: 3873174.
      View in: PubMed
    196. Levine AM, Burkes RL, Walker M, Meyer PR, Gill PS, Nichols PW, Dworsky R, Parker JW, Lukes RJ. B-cell lymphoma in two monogamous homosexual men. Arch Intern Med. 1985 Mar; 145(3):479-81. PMID: 3872108.
      View in: PubMed
    197. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, Levine AM, Lukes RJ, Gill PS, Burkes RL, Meyer PR, Metroka CE. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med. 1984 Aug 30; 311(9):565-70. PMID: 6611504.
      View in: PubMed